Published • loading... • Updated
CEO of Pay Less: Each Real in GLP-1 Generates Other R$ 8,14 - 17/08/2026
Summary by Folha De S.Paulo
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
According to Jonas Marques, CEO of Farms Pay Less, at each R$ 1 spent on GLP-1 receptor agonists, such as Ozempic, Moungharo and Wegovy, the customer spends more R$ 8.14 on other products, on the so-called cross-selling. Read more (08/17/2026
·São Paulo, Brazil
Read Full ArticleCoverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
